These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6305140)

  • 41. [Functional roentgenotherapy of the spleen in chronic myeloid leukemia].
    Cristescu M; Ciobotaru A
    Rev Med Chir Soc Med Nat Iasi; 1967; 73(3):599-606. PubMed ID: 5258929
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results of treatment and survival time in chronic granulocytic leukemia].
    Pawlowski J
    Przegl Lek; 1969; 25(3):305-9. PubMed ID: 4182966
    [No Abstract]   [Full Text] [Related]  

  • 43. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
    Wagner H; McKeough PG; Desforges J; Madoc-Jones H
    Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
    Maurice PA
    Rev Med Suisse Romande; 1970 Jun; 90(6):521-32. PubMed ID: 5293581
    [No Abstract]   [Full Text] [Related]  

  • 45. [Giant nuclei after myleran therapy and spleen irradiation in chronic myeloid leukemia].
    WALLER U
    Pathol Microbiol (Basel); 1960; 23():283-90. PubMed ID: 13842627
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence following splenic radiotherapy for a highly dynamic traffic of CFU-GM between the spleen and other organs in chronic granulocytic leukaemia.
    Morris TC; Vincent PC; Gunz FW; Sutherland R; Zbroja R; Irvine AE; Forrest PR
    Leuk Res; 1987; 11(2):109-17. PubMed ID: 3469481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Modification of the prognosis of chronic myeloid leukemia through current treatment].
    Donner L; Klener P; Roth Z
    Vnitr Lek; 1976 Feb; 22(2):114-9. PubMed ID: 1062868
    [No Abstract]   [Full Text] [Related]  

  • 48. Cytogenetic studies of the spleen in chronic granulocytic leukaemia.
    Spiers AS; Barikie AG; Bartnall JA; Cox JI
    Aust N Z J Med; 1975 Aug; 5(4):295-305. PubMed ID: 1058669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of chronic granulocytic leukemia.
    Can Med Assoc J; 1968 Jul; 99(3):129-30. PubMed ID: 4877613
    [No Abstract]   [Full Text] [Related]  

  • 50. [Regularities in the change in leukocyte count during treatment of chronic myeloid leukosis].
    Emanuél' NM; Sherman SI; Levitin EI; Rozanova LM; Evseenko LS; Kukharenko IuA
    Dokl Akad Nauk SSSR; 1967 Aug; 175(5):1197-200. PubMed ID: 5270825
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of splenic X-irradiation on bone marrow function: experimental studies of a serum mitotic inhibitor in rabbit and in patients with chronic myelocytic leukaemia.
    Maurice PA; Williner B; Gindrat JJ; Brand A
    Br J Haematol; 1969 Dec; 17(6):543-51. PubMed ID: 5261183
    [No Abstract]   [Full Text] [Related]  

  • 52. The treatment of chronic granulocytic leukaemia.
    Spiers AS
    Br J Haematol; 1976 Mar; 32(3):291-8. PubMed ID: 766818
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR; Hurley TH; Bolton JH
    Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolonged remission in chronic myeloid leukemia after one course of busulfan.
    Djaldetti M; Padeh B; Pinkhas J; De Vries A
    Blood; 1966 Jan; 27(1):103-9. PubMed ID: 5216460
    [No Abstract]   [Full Text] [Related]  

  • 55. The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia.
    Gee TS; Cunningham I; Dowling MD; Chaghanti R; Clarkson BD
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):289-93. PubMed ID: 282899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diabetes insipidus in chronic myeloid leukemia. Remission of hypophyseal infiltration during busulfan treatment].
    Eichhorn P; Rhyner K; Haller D; Hämmerli R; Steuli R; Furrer J
    Schweiz Med Wochenschr; 1988 Feb; 118(8):275-9. PubMed ID: 3162777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged remission in chronic myeloid leukemia after a single course of myleran.
    Djaldetti M; Pinkhas J; Padeh B; De Vries A
    Isr J Med Sci; 1965 Jul; 1(4):827-8. PubMed ID: 5216389
    [No Abstract]   [Full Text] [Related]  

  • 58. [Observation of a child with leukemia for 10 years].
    Tonkonog AP
    Probl Gematol Pereliv Krovi; 1967 Aug; 12(8):52-4. PubMed ID: 5260221
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic myelogenous leukemia--new concepts (second of two parts).
    Koeffler HP; Golde DW
    N Engl J Med; 1981 May; 304(21):1269-74. PubMed ID: 7012625
    [No Abstract]   [Full Text] [Related]  

  • 60. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V
    Dtsch Med Wochenschr; 1971 May; 96(20):867-70. PubMed ID: 5280862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.